Benefits of normalizing plasma phenylalanine: Impact on behaviour and health. A case report

Journal of Inherited Metabolic Disease

Volumn 21, Issue 8, 1998, Pages 785-790

  Williams, K ^a  

^a Monson Developmental Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; PARACETAMOL; PHENYLALANINE;

AGED; ARTICLE; AUTOMUTILATION; BEHAVIOR; BLOOD LEVEL; CASE REPORT; DIET RESTRICTION; HUMAN; MALE; MENTAL DEFICIENCY; MUSCLE CRAMP; PHENYLKETONURIA; SOCIAL INTERACTION; TREMOR; WALKING; WELLBEING; BLOOD; DIET THERAPY; GAIT; LEG; MUSCLE SPASM; PATHOPHYSIOLOGY;

AGED; BEHAVIOR; GAIT; HUMANS; LEG; MALE; PHENYLALANINE; PHENYLKETONURIAS; SELF-INJURIOUS BEHAVIOR; SPASM; TREMOR;

EID: 0031593357     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005482732411     Document Type: Article

References (16)

1. Agrawal H, Davison A (1973) Myelination and amino acid imbalance in the developing brain. In Himich WA, ed. Biochemistry of the Developing Brain. New York: Marcel Decker.
2. Diamond A, Herzberg C (1996) Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. Brain 119: 523-538.
3. Hambraeus L, Holmgren G, Samuelson G (1971) Dietary treatment of adult patients with phenylketonuria. Nutr Metab 13: 298-317.
4. Harper M, Reid A H (1987) Use of restricted protein diet in the treatment of behaviour disorder in a severely mentally retarded adult female phenylketonuric patient. J Ment Defic Res 31: 209-212.
5. Hashishe M (1992) Genetic study of phenylketonuria. J Egyp Pub Health Ass 67: 443-463.
6. MacDonald A, Rylance G, Hall S, Asplin D, Booth I (1996) Factors affecting variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch Dis Child 14: 412-417.
7. Malamud N (1966) Neuropathy of phenylketonuria. J Neuropathol Except Neurol 25: 254-268.
8. Martynyuk A, Savina S, Skibo G (1991) Blocking effect of intraperitoneal injection of phenylalanine on gh-threshold calcium currents in rat hippocampal neurons. Brain Res 552: 228-231.
9. McMurry M, Chan G, Leonard C, Ernst S (1992) Bone mineral status in children with phenylketonuria - relationship to nutritional intake and phenylalanine control. Am J Clin Nutr 55: 997-1004.
10. Pietz J, Fatkenheur B, Burgard P, Armbuster M, Esser G, Schmidt H (1997) Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics 99: 345-350.
11. Rouse B, Lockhart L, Matalon R, et al (1990) Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. J Inher Metab Dis 13: 289-291.
12. Thompson A, Smith I, Brenton D, et al (1990) Neurological deterioration in young adults with phenylketonuria. Lancet 336: 602-605.
13. Villasana D, Butler I, Williams J, Roongta S (1989) Neurological deterioration in adult phenylketonuria. J Inher Meta Dis 12: 451-457.
14. Waisbren S, Levy H (1991) Agoraphobia in phenylketonuria. J Inher Metab Dis 14: 755-764.
15. Waisbren S, Schnell R, Levy H (1980) Diet termination in children with PKU: a review of psychological assessments used to determine outcome. J Inher Metab Dis 3: 149-153.
16. Yanicelli S, Ryan A (1995) Improvements is behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a national survey. J Inher Metab Dis 18: 131-134.